000 01462 a2200421 4500
005 20250517035854.0
264 0 _c20160411
008 201604s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2015.05.091
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchiffler, Matthew A
245 0 0 _aDiscovery and characterization of a potent and selective EP4 receptor antagonist.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cAug 2015
300 _a3176-8 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalgesics
_xchemistry
650 0 4 _aAnimals
650 0 4 _aBlood Cells
_xcytology
650 0 4 _aDogs
650 0 4 _aHalf-Life
650 0 4 _aHumans
650 0 4 _aLipopolysaccharides
_xtoxicity
650 0 4 _aProtein Binding
650 0 4 _aReceptors, Prostaglandin E, EP4 Subtype
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aChandrasekhar, Srinivasan
700 1 _aFisher, Matthew J
700 1 _aHarvey, Anita
700 1 _aKuklish, Steven L
700 1 _aWang, Xu-Shan
700 1 _aWarshawsky, Alan M
700 1 _aYork, Jeremy S
700 1 _aYu, Xiao-Peng
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 25
_gno. 16
_gp. 3176-8
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2015.05.091
_zAvailable from publisher's website
999 _c24998633
_d24998633